<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20160221026674N9</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-01-24</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Studying the effect of needling muscles attached to the iliotibial band on clinical symptoms of patients with iliotibial band syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Comparing of the effect of gluteus maximus, gluteus medius, and tensor fascia lata muscle needling versus sham needling on the findings of clinical tests and symptoms in patients with iliotibial band syndrome: A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-01-31</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/87924</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The randomization method in this study will be the permutation block method, which will be generated using the PASS 2021 software. A desired random list, consisting of 5 blocks of 6, will be generated. The project manager will carry out this process.
The allocation of samples will be done in a 1:1 ratio. In order to conceal the allocation, opaque and sealed envelopes will be used, which will be opened by the therapist after the evaluation process is completed by the evaluator, Blinding description: The assessor and the therapist are two separate individuals, and the assessor is blind to the intervention groups. Patients are unaware of the intervention when receiving the sham needling technique.</study_design>
      <phase>3</phase>
      <hc_freetext>Iliotibial band syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:10 sessions of Burst TENS with a pulse frequency of 100 Hz and a burst frequency of 10 Hz, a pulse width of 200 microseconds, for 20 minutes10 sessions of continuous ultrasound (duty cycle 100%), with a frequency of 3 MHz, an intensity of 1 W/cm2, and a duration of 5 minutes10 sessions of hot packs for 20 minutes10 sessions of stretching exercises for the tensor fascia lata, gluteus maximus, and gluteus medius muscles in four sets of 30 seconds5 sessions (every other day) of static dry needling in the motor points of the tensor fascia lata, gluteus maximus, and gluteus medius muscles for 20 minutes. Intervention 2: Control group: 10 sessions of Burst TENS with a pulse frequency of 100 Hz and a burst frequency of 10 Hz, a pulse width of 200 microseconds, for 20 minutes10 sessions of continuous ultrasound (duty cycle 100%), with a frequency of 3 MHz, an intensity of 1 W/cm2, and a duration of 5 minutes10 sessions of hot packs for 20 minutes10 sessions of stretching exercises for the tensor fascia lata, gluteus maximus, and gluteus medius muscles in four sets of 30 seconds5 sessions (every other day) of sham dry needling in the the tensor fascia lata, gluteus maximus, and gluteus medius muscles with guide pressure and without entering the patient's body.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data collection form including primary and secondary outcomes, informed consent form, and SPSS file

When:
After the publication of the study results

To whom:
Researchers working in academic and scientific institutions

Conditions:
Recording information in scientific databases

Where to obtain:
Correspondence with the project manager by email. mohamadm@sums.ac.ir

How to obtain:
Maximum one month after sending the request by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, after Amir-al-Momenin Burn Accident Hospital, Shahid Doran Campus, Sadra Town Road</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7198754361</zip>
        <telephone>+98 71 3212 2600</telephone>
        <email>mohamadm@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzieh Mohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, after Amir-al-Momenin Burn Accident Hospital, Shahid Doran Campus, Sadra Town Road</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7198754361</zip>
        <telephone>+98 71 3212 2600</telephone>
        <email>mohamadm@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with iliotibial band syndrome in the subacute or chronic phase of the disease
Aged between 18 and 45 years
Presence of pain and tenderness (4 or higher on the numerical pain scale) at the site of attachment of the band to the lateral epicondyle of the femur
Activity level 5 to 10 according to the Tegner scale</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Body mass index greater than 30
Any orthopedic or neurological disorder
A history of knee injury or history of knee physiotherapy in the previous 12 months
Limited range of motion
Fibromyalgia or chronic pain syndrome
Systemic inflammatory diseases
Corticosteroid injections or use of anti-inflammatory drugs in the past month
Phobia of needles
Use of anticoagulant drugs
Uncontrolled diabetes
Any musculoskeletal disorder in the lower extremities except iliotibial band syndrome</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M76.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Iliotibial band syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:10 sessions of Burst TENS with a pulse frequency of 100 Hz and a burst frequency of 10 Hz, a pulse width of 200 microseconds, for 20 minutes10 sessions of continuous ultrasound (duty cycle 100%), with a frequency of 3 MHz, an intensity of 1 W/cm2, and a duration of 5 minutes10 sessions of hot packs for 20 minutes10 sessions of stretching exercises for the tensor fascia lata, gluteus maximus, and gluteus medius muscles in four sets of 30 seconds5 sessions (every other day) of static dry needling in the motor points of the tensor fascia lata, gluteus maximus, and gluteus medius muscles for 20 minutes</i_keyword>
      <i_keyword>Control group: 10 sessions of Burst TENS with a pulse frequency of 100 Hz and a burst frequency of 10 Hz, a pulse width of 200 microseconds, for 20 minutes10 sessions of continuous ultrasound (duty cycle 100%), with a frequency of 3 MHz, an intensity of 1 W/cm2, and a duration of 5 minutes10 sessions of hot packs for 20 minutes10 sessions of stretching exercises for the tensor fascia lata, gluteus maximus, and gluteus medius muscles in four sets of 30 seconds5 sessions (every other day) of sham dry needling in the the tensor fascia lata, gluteus maximus, and gluteus medius muscles with guide pressure and without entering the patient's body</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Before, one day after and two weeks after treatment. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Lower Limb Function. Timepoint: Before, one day after and two weeks after treatment. Method of measurement: Lower extremity functional scale.</sec_outcome>
      <sec_outcome>The findings from the Rene, Noble, Uber, and modified Thomas diagnostic tests. Timepoint: Before, one day after and two weeks after treatment. Method of measurement: Positive or negative test result.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Personal</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-12-03</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Ethics committee, Research and Technology Vice-Chancellor, 7th floor, central building of Shiraz University of Medical Sciences, Zand Street Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
